GlaxoSmithKline PLC Director/PDMR Shareholding (2584X)
May 04 2016 - 8:55AM
UK Regulatory
TIDMGSK
RNS Number : 2584X
GlaxoSmithKline PLC
04 May 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R (1) (a) I give details of changes
in the interests of Mr Roger Connor, a Person Discharging
Managerial Responsibilities, in the ordinary shares of
GlaxoSmithKline plc (the "Company") following the exercise of nil
cost options over 2,029 and 2,156 ordinary shares on 4 May 2016,
granted on 28 February 2013, which vested on 28 February 2016 under
the GlaxoSmithKline Deferred Annual Bonus Plan. The Company
delivered the net of tax value in shares being 2,178. The fair
market value of an ordinary share at the points of exercise on 4
May 2016 was GBP14.69 and GBP14.68 respectively.
The Company and Mr Connor were advised of these transactions on
4 May 2016.
V A Whyte
Company Secretary
4 May 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHXZLFBQEFEBBX
(END) Dow Jones Newswires
May 04, 2016 09:55 ET (13:55 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024